Literature DB >> 22892583

Visual recovery after corneal crosslinking for keratoconus: a 1-year follow-up study.

Ivo Guber1, Josef Guber, Claude Kaufmann, Lucas M Bachmann, Michael A Thiel.   

Abstract

PURPOSE: To evaluate visual recovery and intraocular straylight in keratoconus patients 3 months and 1 year after corneal crosslinking (CXL) PATIENTS AND METHODS: Thirty-three eyes of 28 consecutive patients with mild to moderate keratoconus were included. The following were assessed at baseline, 3 months and 1 year after CXL: corrected distance visual acuity (CDVA), intraocular straylight, spherical equivalent (SE), keratometry (Kmax and K min (Diopters D and axis), the regularity index and pachymetry. Changes from baseline were calculated using mixed linear regression models.
RESULTS: The CDVA remained unchanged 3 months after CXL (-0.003 (95 % CI: -0.038 to 0.044); p = 0.880) and improved after 1 year (-0.042 (95 % CI: -0.078 to -0.007; p = 0.021)). The mean straylight value increased significantly by 0.27 (95 % CI: 0.18 to 0.35; p < 0.001) 3 months after CX and normalized to preoperative values after 1 year (0.06 (95 % CI: -0.03 to 0.14; p = 0.215)). SE improved from the mean preoperative value of -2.61 D (95 % CI: -3.83 to -1.39) by 1.95 (95 % CI: 1.03 to 2.86; p < 0.001) at 3 months and remained stable at the 1-year follow-up visit (2.17 (95 % CI: 1.21 to 3.12; p < 0.001)). Parameters of of keratometry changed only minimally. The regularity index remained almost unchanged at 3 months (2.45 (95 % CI: -4.97 to 9.88; p = 0.503)) and decreased by 6.97 (95 % CI: -14.08 to 0.14; p = 0.054). Pachymetry decreased by 44.0 μm (95 % CI: 56.1 to 31.9; p < 0.001) at 3 months and almost returned to preoperative values at 12 months (-11.3 μm (95 % CI: -27.9 to 5.3; p = 0.175)).
CONCLUSIONS: In accordance with the decrease in CDVA and patients' complaints of disability due to glare, intraocular straylight increased 3 months after surgery. One year after CXL, there was an increase in CDVA due to an improved SE and regularity index, and intraocular straylight had normalized.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22892583     DOI: 10.1007/s00417-012-2133-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

1.  Corneal cross-linking-induced stromal demarcation line.

Authors:  Theo Seiler; Farhad Hafezi
Journal:  Cornea       Date:  2006-10       Impact factor: 2.651

2.  Longitudinal changes in visual acuity in keratoconus.

Authors:  Larry J Davis; Kenneth B Schechtman; Brad S Wilson; Carol E Rosenstiel; Colleen H Riley; David P Libassi; Ralph E Gundel; Louis Rosenberg; Mae O Gordon; Karla Zadnik
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-02       Impact factor: 4.799

3.  Compensation comparison method for assessment of retinal straylight.

Authors:  Luuk Franssen; Joris E Coppens; Thomas J T P van den Berg
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-02       Impact factor: 4.799

4.  Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results.

Authors:  Frederik Raiskup-Wolf; Anne Hoyer; Eberhard Spoerl; Lutz E Pillunat
Journal:  J Cataract Refract Surg       Date:  2008-05       Impact factor: 3.351

5.  Computer-assisted corneal topography in keratoconus.

Authors:  Y S Rabinowitz; P J McDonnell
Journal:  Refract Corneal Surg       Date:  1989 Nov-Dec

Review 6.  Crosslinking treatment of progressive keratoconus: new hope.

Authors:  Gregor Wollensak
Journal:  Curr Opin Ophthalmol       Date:  2006-08       Impact factor: 3.761

7.  Riboflavin-Ultraviolet A Corneal Cross-linking for Keratoconus.

Authors:  Tamer M El-Raggal
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

8.  Effect of complete epithelial debridement before riboflavin-ultraviolet-A corneal collagen crosslinking therapy.

Authors:  Sally Hayes; David P O'Brart; Letitia S Lamdin; James Doutch; Kostas Samaras; John Marshall; Keith M Meek
Journal:  J Cataract Refract Surg       Date:  2008-04       Impact factor: 3.351

9.  Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment.

Authors:  Gregor Wollensak; Eberhard Spoerl; Michaela Wilsch; Theo Seiler
Journal:  Cornea       Date:  2004-01       Impact factor: 2.651

10.  Assessing the reliability, discriminative ability, and validity of disability glare tests.

Authors:  D B Elliott; M A Bullimore
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-01       Impact factor: 4.799

View more
  5 in total

Review 1.  Safety and efficacy of epithelium removal and transepithelial corneal collagen crosslinking for keratoconus.

Authors:  Z Shalchi; X Wang; M A Nanavaty
Journal:  Eye (Lond)       Date:  2014-10-03       Impact factor: 3.775

2.  First experience with Oasis Collagen SOFT SHIELD® for epithelial defect after corneal cross-linking.

Authors:  Ivo Guber; Ciara Bergin; Shruti Malde; Josef Guber; Samer Hamada; Damian Lake
Journal:  Int Ophthalmol       Date:  2019-01-18       Impact factor: 2.031

3.  Identifying more reliable parameters for the detection of change during the follow-up of mild to moderate keratoconus patients.

Authors:  Ivo Guber; Colm McAlinden; François Majo; Ciara Bergin
Journal:  Eye Vis (Lond)       Date:  2017-10-25

Review 4.  Collagen cross-linking: when and how? A review of the state of the art of the technique and new perspectives.

Authors:  Leonardo Mastropasqua
Journal:  Eye Vis (Lond)       Date:  2015-11-29

5.  Corneal collagen crosslinking for progressive keratoconus in Saudi Arabia: One-year controlled clinical trial analysis.

Authors:  Ashbala Khattak; Fouad R Nakhli; Haider R Cheema
Journal:  Saudi J Ophthalmol       Date:  2015-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.